在肺纤维化和肺移植后的结果中强迫性生命能力减弱的严重程度
Manon Levêque1, Julien Bermudez1, Ana Nieves1
1Aix-Marseille University, Department of Respiratory Medicine, and Lung Transplantation, APHM, Marseille France.
Respiratory medicine and research
|February 13, 2025
概括
在为间歇性肺病 (ILD) 进行肺移植 (LTx) 之前,强迫性生命能力 (FVC) 的严重减少与更糟糕的结果有关. 46%或更低的FVC值表明LTx后死亡风险较高.
科学领域:
- 肺部病理学 肺部病理学
- 移植手术 移植手术
- 关键护理医学 关键护理医学
背景情况:
- 间歇性肺病 (ILD) 需要及时的肺移植 (LTx) 转诊,因为其进展不可预测.
- 强迫生命能力 (FVC) 减轻严重程度对ILD患者LTx结果的影响仍然没有研究.
- 这项研究调查了FVC减少严重程度与ILD中LTx后结果之间的关联.
研究的目的:
- 确定移植前强制性生命能力 (FVC) 减少的严重程度是否会影响肺移植 (LTx) 结果在患有间歇性肺病 (ILD) 的患者中.
主要方法:
- 对从法国多中心COLT队列中接受LTx的311名ILD患者的分析.
- 评估移植前的FVC减轻严重程度作为LTx后结果的预测指标.
- 使用多变量分析和ROC曲线来确定FVC值和相关风险.
主要成果:
- 移植前的FVC减轻严重程度是1年死亡率的重要风险因素 (p=0.003).
- 确定了46%的最佳FVC值,预测一年死亡率的AUC为64%.
- 患有FVC ≤46%的患者有更高的紧急清单率,更低的一年FVC,以及短期和长期存活率降低.
结论:
- 移植前的FVC减轻严重程度是导致ILD肺移植结果较差的关键风险因素.
- 低于46%的FVC值应该为LTx指示,单个LTx决定和供体肺部选择提供信息.
- 对于ILD患者来说,早期转诊到LTx中心至关重要,特别是那些显著减少FVC的患者.
相关概念视频
01:25Pulmonary Function Tests
290
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
290
01:26Flail Chest-II
158
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
158
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:29Acute Respiratory Failure-V
117
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
117
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:21Acute Respiratory Failure-II
159
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
159